CARE

NEUTRALEarnings

Carter Bankshares, Inc.

2026-06-18

Price

$30.96

+0.19%

This is the 2026-06-18 snapshot — the signals and analysis for CARE as of this single trading day.

View full CARE research hub →

Score4.2Watchlist

Signals3/8 DNA0/13 Act · 2/4 Risk

SentimentNEUTRALScore: 8

Volume3.0xvs 20d avg

Analysis

CARE is exhibiting a textbook bullish divergence, absorbing a massive Q1 earnings miss as institutions focus on structural balance sheet improvements. The recent $289.48 million cash sale of legacy nonperforming loans tied to James C. Justice II and the reinstatement of a $0.10 quarterly dividend have triggered a fundamental re-rating. Operating in a RISK_ON regime where credit markets are aggressively ignoring Fed hawkishness, urgent volume and strong technical signals (ALPHA_MALE, PERFECT_STACK) confirm high-conviction price discovery as the market looks forward to a de-risked future.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACKWEAK FINISHCHURNING

Key Takeaways

Structural De-risking: The market is entirely ignoring an 85% Q1 EPS miss ($0.40 vs ~$2.80 expected) [1.2.1], rewarding CARE for liquidating $289.48M in legacy nonperforming loans and reinstating its dividend.
Upcoming Catalysts: Investors are looking past the Q1 miss to Q2, where CARE expects to record a $35.8M pre-tax gain from the sale of its interest in Bearing Insurance Group.
Institutional Accumulation: A massive +15.1% relative strength vs SPY, combined with 3.0x average volume and PERFECT_STACK signals, indicates aggressive institutional buying despite the optical earnings shock.

← Back to 2026-06-18 View Full CARE History →Yahoo Finance &nearr;